Cite
HARVARD Citation
Sánchez-Rovira, P. et al. (2021). Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria. Medicine. 100 (29), p. . [Online].